Noxopharm Ltd.

Noxopharm Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.09
Market Cap
AUD58.85 M
Shares Outstanding
122.6 M
Public Float
59.08 M

Profile

Address
828 Pacific Highway
Gordon New South Wales (NSW) 2072
Australia
Employees -
Website http://www.noxopharm.com
Updated 07/08/2019
Noxopharm Ltd. engages in the research and development of drugs. It focuses on sensitizing cancer cells to radiotherapy and chemotherapy. The company was founded by Graham Kelly on October 27, 2015 and is headquartered in Gordon, Australia.

Financials

View All

Graham Edmund Kelly
Chief Executive Officer, MD & Director
Ian Dixon
Non-Executive Director